As the semaglutide patent expiries begin in 2026 across key global markets, Indian pharma companies are racing to capture the opportunity amid rising competition, falling prices & regulatory uncertainty Ekta Bhatra breaks down who stands to gain, the risks ahead, & how GLP-1 drugs could drive the next phase of pharma growth
more Celdyque PDRN 12% + EGF Peptide Serum Serum with 36 ingredients, including niacinamide, exfoliants, and hyaluronic acid
By binding to GLP-1 receptors in the brain, semaglutide suppresses hunger signals, reducing food intake and calorie consumption
L-carnitine: searching for new therapeutic strategy for sepsis management
It feels really good to lose this much weight, especially because I never thought I could. Learn more about LifeMD and Triple Therapy here
However, Trulicity is not approved for weight loss